153 related articles for article (PubMed ID: 7985031)
1. Mutant mice, Cu,Zn superoxide dismutase, and motor neuron degeneration.
McCord JM
Science; 1994 Dec; 266(5190):1586-7. PubMed ID: 7985031
[No Abstract] [Full Text] [Related]
2. ALS-linked Cu/Zn-SOD mutation increases vulnerability of motor neurons to excitotoxicity by a mechanism involving increased oxidative stress and perturbed calcium homeostasis.
Kruman II; Pedersen WA; Springer JE; Mattson MP
Exp Neurol; 1999 Nov; 160(1):28-39. PubMed ID: 10630188
[TBL] [Abstract][Full Text] [Related]
3. Oxidative stress, mutant SOD1, and neurofilament pathology in transgenic mouse models of human motor neuron disease.
Tu PH; Gurney ME; Julien JP; Lee VM; Trojanowski JQ
Lab Invest; 1997 Apr; 76(4):441-56. PubMed ID: 9111507
[TBL] [Abstract][Full Text] [Related]
4. Partial deficiency of manganese superoxide dismutase exacerbates a transgenic mouse model of amyotrophic lateral sclerosis.
Andreassen OA; Ferrante RJ; Klivenyi P; Klein AM; Shinobu LA; Epstein CJ; Beal MF
Ann Neurol; 2000 Apr; 47(4):447-55. PubMed ID: 10762155
[TBL] [Abstract][Full Text] [Related]
5. [Familial amyotrophic lateral sclerosis and mutations in the Cu/Zn superoxide dismutase gene].
Nakano R
Rinsho Shinkeigaku; 1995 Dec; 35(12):1546-8. PubMed ID: 8752459
[TBL] [Abstract][Full Text] [Related]
6. Mitochondrial alterations in transgenic mice with an H46R mutant Cu/Zn superoxide dismutase gene.
Sasaki S; Aoki M; Nagai M; Kobayashi M; Itoyama Y
J Neuropathol Exp Neurol; 2009 Apr; 68(4):365-73. PubMed ID: 19287315
[TBL] [Abstract][Full Text] [Related]
7. Identification of three mutations in the Cu,Zn-superoxide dismutase (Cu,Zn-SOD) gene with familial amyotrophic lateral sclerosis: transduction of human Cu,Zn-SOD into PC12 cells by HIV-1 TAT protein basic domain.
Chou CM; Huang CJ; Shih CM; Chen YP; Liu TP; Chen CT
Ann N Y Acad Sci; 2005 May; 1042():303-13. PubMed ID: 15965076
[TBL] [Abstract][Full Text] [Related]
8. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation.
Gurney ME; Pu H; Chiu AY; Dal Canto MC; Polchow CY; Alexander DD; Caliendo J; Hentati A; Kwon YW; Deng HX
Science; 1994 Jun; 264(5166):1772-5. PubMed ID: 8209258
[TBL] [Abstract][Full Text] [Related]
9. Enhanced oxygen radical production in a transgenic mouse model of familial amyotrophic lateral sclerosis.
Liu R; Althaus JS; Ellerbrock BR; Becker DA; Gurney ME
Ann Neurol; 1998 Nov; 44(5):763-70. PubMed ID: 9818932
[TBL] [Abstract][Full Text] [Related]
10. Superoxide dismutase and neurofilament transgenic models of amyotrophic lateral sclerosis.
Morrison BM; Morrison JH; Gordon JW
J Exp Zool; 1998 Sep-Oct 1; 282(1-2):32-47. PubMed ID: 9723164
[TBL] [Abstract][Full Text] [Related]
11. Transgenics, toxicity and therapeutics in rodent models of mutant SOD1-mediated familial ALS.
Turner BJ; Talbot K
Prog Neurobiol; 2008 May; 85(1):94-134. PubMed ID: 18282652
[TBL] [Abstract][Full Text] [Related]
12. Pathogenic mechanisms in familial amyotrophic lateral sclerosis due to mutation of Cu, Zn superoxide dismutase.
Gurney ME; Cutting FB; Zhai P; Andrus PK; Hall ED
Pathol Biol (Paris); 1996 Jan; 44(1):51-6. PubMed ID: 8734301
[TBL] [Abstract][Full Text] [Related]
13. Familial amyotrophic lateral sclerosis (FALS): Emerging hints from redox proteomics. Highlight commentary on: "Redox proteomics analysis of oxidatively modified proteins in G93A-SOD1 transgenic mice--a model of familial amyotrophic lateral sclerosis".
Dalle-Donne I
Free Radic Biol Med; 2007 Jul; 43(2):157-9. PubMed ID: 17603924
[No Abstract] [Full Text] [Related]
14. Loss of prion protein in a transgenic model of amyotrophic lateral sclerosis.
Dupuis L; Mbebi C; Gonzalez de Aguilar JL; Rene F; Muller A; de Tapia M; Loeffler JP
Mol Cell Neurosci; 2002 Feb; 19(2):216-24. PubMed ID: 11860274
[TBL] [Abstract][Full Text] [Related]
15. Neuromuscular dysfunction in the mutant superoxide dismutase mouse model of amyotrophic lateral sclerosis.
Parkhouse WS; Cunningham L; McFee I; Miller JM; Whitney D; Pelech SL; Krieger C
Amyotroph Lateral Scler; 2008; 9(1):24-34. PubMed ID: 18273716
[TBL] [Abstract][Full Text] [Related]
16. Midbrain dopaminergic neuronal degeneration in a transgenic mouse model of familial amyotrophic lateral sclerosis.
Kostic V; Gurney ME; Deng HX; Siddique T; Epstein CJ; Przedborski S
Ann Neurol; 1997 Apr; 41(4):497-504. PubMed ID: 9124807
[TBL] [Abstract][Full Text] [Related]
17. Highlight Commentary on "Redox proteomics analysis of oxidatively modified proteins in G93A-SOD1 transgenic mice--a model of familial amyotrophic lateral sclerosis".
Calabrese V
Free Radic Biol Med; 2007 Jul; 43(2):160-2. PubMed ID: 17603925
[TBL] [Abstract][Full Text] [Related]
18. Superoxide-dependent peroxidase activity of H48Q: a superoxide dismutase variant associated with familial amyotrophic lateral sclerosis.
Liochev SI; Chen LL; Hallewell RA; Fridovich I
Arch Biochem Biophys; 1997 Oct; 346(2):263-8. PubMed ID: 9343373
[TBL] [Abstract][Full Text] [Related]
19. Copper, zinc superoxide dismutase (SOD1) and its role in neuronal function and disease with particular relevance to motor neurone disease/amyotrophic lateral sclerosis.
de Belleroche J; Orrell RW; Virgo L; Habgood J; Gardiner IM; Malaspina A; Kaushik N; Mitchell J; Greenwood J
Biochem Soc Trans; 1998 Aug; 26(3):476-80. PubMed ID: 9765899
[No Abstract] [Full Text] [Related]
20. Superoxide dismutase activity in lymphoblastoid cells from motor neurone disease/amyotrophic lateral sclerosis (MND/ALS) patients.
Garofalo O; Figlewicz DA; Thomas SM; Butler R; Lebuis L; Rouleau G; Meininger V; Leigh PN
J Neurol Sci; 1995 May; 129 Suppl():90-2. PubMed ID: 7595631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
